by Catherine Pittman, Ph.D. | Nov 2, 2018 | Blog, Public Awareness Campaigns
Presented at the Indiana Attorney General’s Drug Abuse Symposium on October 30, 2018. Presentation Video Presentation Slides [pdf-embedder url=”https://benzoinfo.com/wp-content/uploads/2018/11/Overlooked-Risks-of-Benzodiazepine-Use.pdf”...
by Benzodiazepine Information Coalition | Dec 13, 2017 | Blog, Public Awareness Campaigns
Benzodiazepines are the pharmaceutical industry’s top-selling family of prescription drugs. Alprazolam, also known as Xanax, has long been among the industry’s best-selling pills. There are now 94 million prescriptions for various benzodiazepines in the U.S. alone...
by Nicole Lamberson, PA | Dec 11, 2017 | Blog, Public Awareness Campaigns
This blog responds to a particularly inaccurate article published in the Aiken Standard by Dr. Greg Smith, a psychiatrist from Aiken, South Carolina. The original article can be read here. Dr. Smith’s statements from the article are bolded and italicized for...
by Holly Hardman | Aug 30, 2017 | Blog, Public Awareness Campaigns
As Prescribed, a documentary film about the benzodiazepine epidemic and the iatrogenic nature of benzodiazepine illness and disability, expects to complete production this year. The film’s director, Holly Hardman, is a survivor of benzodiazepine injury, and is...
by Christy Huff, M.D | Jul 27, 2017 | Blog, Call to Action, Public Awareness Campaigns
In October 2016, I wrote an open letter detailing my withdrawal and the dangers of benzodiazepine withdrawal syndrome. Many have asked how I am doing since that time. I’m going to be completely open and honest in this update. Things have been extremely rough. I have...
by Lori J. Heckenkamp | Jun 4, 2017 | Blog, Public Awareness Campaigns
Note: Lori Heckenkamp passed away on July 14, 2017. Dear Dr. X, My name is Lori Jean Heckenkamp. I am 57 and a patient at the Cancer Center where you head the gynecologic oncology group. I began treatment in June, 2015 for advanced ovarian cancer. I will soon be free...
Recent Comments